191 related articles for article (PubMed ID: 11872915)
21. Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke.
Gallus AS
Haemostasis; 2000; 30 Suppl 2():64-71; discussion 63. PubMed ID: 11251344
[TBL] [Abstract][Full Text] [Related]
22. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
Counsell C; Sandercock P
Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
[No Abstract] [Full Text] [Related]
23. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
24. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
25. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
[TBL] [Abstract][Full Text] [Related]
26. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.
Sandercock P; Mielke O; Liu M; Counsell C
Cochrane Database Syst Rev; 2003; (1):CD000248. PubMed ID: 12535394
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulation in acute ischemic stroke: A systematic search.
Froio NL; Montgomery RM; David-Neto E; Aprahamian I
Rev Assoc Med Bras (1992); 2017 Jan; 63(1):50-56. PubMed ID: 28225876
[TBL] [Abstract][Full Text] [Related]
28. Hemorrhagic Transformation of Arterial Ischemic and Venous Stroke in Children.
Hutchinson ML; Beslow LA
Pediatr Neurol; 2019 Jun; 95():26-33. PubMed ID: 30904397
[TBL] [Abstract][Full Text] [Related]
29. Low-molecular-weight heparins and heparinoids in acute ischemic stroke : a meta-analysis of randomized controlled trials.
Bath PM; Iddenden R; Bath FJ
Stroke; 2000 Jul; 31(7):1770-8. PubMed ID: 10884486
[TBL] [Abstract][Full Text] [Related]
30. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
31. Hemorrhagic transformation in patients with acute ischaemic stroke and an indication for anticoagulation.
Marsh EB; Llinas RH; Hillis AE; Gottesman RF
Eur J Neurol; 2013 Jun; 20(6):962-7. PubMed ID: 23521544
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials.
Paciaroni M; Agnelli G; Micheli S; Caso V
Stroke; 2007 Feb; 38(2):423-30. PubMed ID: 17204681
[TBL] [Abstract][Full Text] [Related]
33. A systematic review of immediate anticoagulation for ischemic stroke of presumed cardioembolic origin.
Guedes LC; Ferro JM
Stroke; 2008 May; 39(5):e81-2; author reply e83. PubMed ID: 18369164
[No Abstract] [Full Text] [Related]
34. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
[TBL] [Abstract][Full Text] [Related]
35. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
36. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
Calvet D; Bracard S; Mas JL;
Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
[TBL] [Abstract][Full Text] [Related]
38. Letters on management of ischemic stroke.
Porat G
Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
[No Abstract] [Full Text] [Related]
39. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke.
Andersen KK; Olsen TS
Stroke; 2007 Feb; 38(2):259-63. PubMed ID: 17194876
[TBL] [Abstract][Full Text] [Related]
40. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Counsell C; Tseng MC
Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
